scorecardresearch
Add as a preferred source on Google
Wednesday, October 8, 2025
TopicUSFDA

Topic: USFDA

How the humble hydroxychloroquine has become India’s unlikely new global strategic asset

Donald Trump has labelled hydroxychloroquine a 'game-changer' in the fight against Covid-19. Indian pharma companies have gained significantly from this.

US FDA orders removal of ranitidine drugs from market over ‘carcinogen contamination’

Ranitidine is available in India under brand names of Aciloc and Zinetac but FDA specifically names Sanofi’s Zantac.

Torrent Pharma warned by US again, this time for using bacteria-contaminated water system

In the last 11 months, USFDA has issued 23 warning letters to Indian drugmakers. For Torrent Pharma, it's the third this year.

On Camera

Once you know how UPA handled illegal Bangladeshi immigrants, you see Modi govt’s propaganda

The 'ghuspaithiya' narrative is being whipped up precisely when illegal immigration has actually diminished. Like most BJP-RSS ideas, it’s just an unimaginative Right-wing trope.

Vietnam & China cutting into India’s footwear exports, NITI Aayog calls for tariff cuts, R&D push

With non-leather products driving global footwear demand between 2020 and 2024, India’s global market share stood at 1.85% in 2024, says a NITI Aayog report.

ISKP & Lashkar converging under aegis of Pakistan’s ISI to take on Baloch fighters

ISKP, a sub-continental branch of the Islamic State, is said to have vowed to extend operations in Kashmir, on encouragement from Pakistan’s security establishment.

How Pakistan thinks: Army for hire, ideology of convenience

Pakistan’s army has been a rentier force available to a reasonable bidder. It has never come to the aid of any Muslims including Palestinians or the Gazans, except making noises here and there.